Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 09, 2024 4:37pm
132 Views
Post# 35818198

RE:AEZS close... WTF?

RE:AEZS close... WTF?
PBaelishh wrote: Anybody have any ideas as to why AEZS went up 20% or .36 today?


This is the first full week of the New Year. It's back to work.
More details on the merger expected around the end of the month.

H.C. Wainwright had a US$15 target on AEZS before a recent huge spike in biotech. It's only at US$2.18!

$2.18
0.26 | 
13.54%
 


US$15 works out to a market cap target of ~C$100 million for AEZS. As a merger of equals with each company's shareholders controlling 50% of the new company the new company could be seen as having a C$200 million market cap target price with events(eg. diagnostic results, licensing deal, PGX scale-up, PGX licensing deal, etc.).   

<< Previous
Bullboard Posts
Next >>